New York City, NY, 25 February, 2020/ 24 Market Reports: It is estimated for the sterile filtration market to grow from USD 4.4 billion in 2019 and reach that of USD 7.8 billion by 2025, witnessing the growth at a CAGR of 8.2% during the forecast period of 2019 to 2025. The advantages of sterile filters over non-sterile filters, the growth in the demand for pure water in the end-use industries, the increased adoption of single-use devices & disposables and the rising focus on the development of large molecule biopharmaceutical drugs are the factors that are driving the growth of the market during the forecast period. However, price sensitivity is the factor that is hindering the growth of the market during the forecast period.
Cartridge filters, capsule filters, membranes, syringe filters, bottle-top & table-top filtration systems and accessories are the segmentation for the market based on the product. During the forecast period, it is estimated for the cartridge filters segment to account for the largest share in the market. The increasing use of different types of cartridges filters for larger processes requiring more filtration area and/or lower unit operating cost and high flow rates & high throughput is driving the growth of the market during the forecast period.
Based on the end-user, it is estimated for the biopharmaceutical company segment to witness the highest growth in the market during the forecast period. Increasing demand in cell separation is the factor that is driving the growth of the market during the forecast period. In the biopharmaceutical manufacturing, the volume of feed is relatively low, but the degree of difficulty with filter plugging is considerably high and sterile filters are used throughout the process. The application of the sterile filters is found extensively in the biopharmaceutical industry because the biopharmaceutical products and their intermediates are susceptible to degradation because of the heat and chemical treatment and are difficult to separate using other techniques.
Owing to the use of sterile filters in the fill-finish process of manufacturing of sterile products and demands the highest level of quality and reliability, the fill-finish processes segment, by application, is expected to show the highest growth in the forecast period. As the aseptic filling of sterile drugs, also known as sterile filling, remains as one of the most critical processes in biopharmaceutical manufacturing, the factor is estimated to drive the growth of the sterile fillers for the fill-finish segment during the forecast period.
Due to the hydrophilic nature of PES, its low protein-binding properties and a wide range of applications, it is estimated for the PES segment to register the highest growth in the market during the forecast period.
Owing to its use in wide range of pharmaceutical and biological liquid applications, including the filtration of therapeutics, vaccines, antibiotics, blood fractionations, bulk pharmaceuticals, and other downstream biotechnology processing solutions, where protein binding must be minimized, it is estimated for the 0.2–0.22 ?m segment to grow at the highest rate in the market during the forecast period.
Europe, North America, Asia Pacific, LATAM and the MEA are the segmentation for the market based on geography. Followed by Europe, it is estimated for North America to account for the largest share in the market during the forecast period. The strong presence of sterile product manufacturers in the region, well-established biopharmaceutical industry, significant R&D spending by pharmaceutical and biotechnology companies, and the presence of a well-established intellectual property system for innovative biologics production are the factors that are driving the growth of the sterile filtration market in North America during the forecast period. Owing to the growing contract-manufacturing base in the region, it is estimated for the Asia Pacific region to grow at the highest CAGR in the market during the forecast period.